{"schema_version":"secwatch.filing_event.v1","accession":"0001829126-25-009754","form_type":"8-K","ticker":"NTHI","cik":"0001979414","company_name":"NEONC TECHNOLOGIES HOLDINGS, INC.","filed_at":"2025-12-05T23:59:59+00:00","discovered_at":"2026-05-14T18:02:41.205748+00:00","generated_at":"2026-05-16T14:21:18.789617+00:00","sec_items":["1.01","3.02","7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"NeOnc raises $1M from Saad Naja; AI study shows ultrasound boosts NEO100 against brain tumors","bullets":["Issued 111,732 shares at $8.95 to Saad Naja, raising gross proceeds of ~$1M for working capital.","Preclinical collaboration with USC (bioRxiv) shows NEO100 combined with focused ultrasound enhances tumor killing in glioblastoma, medulloblastoma, meningioma, and metastases.","AI-trained platform using 200+ molecular descriptors identified NEO100 as a leading sonosensitizer; 3D-bioprinted organoids validated results in days vs. weeks.","Results support moving NEO100-plus-ultrasound into future clinical trials for multiple primary and metastatic brain tumors.","CEO Heshmatpour says findings expand NEO100's commercial and clinical opportunity beyond current indications."],"urls":{"canonical":"https://secwatch.observer/filing/0001829126-25-009754","json":"https://secwatch.observer/filing/0001829126-25-009754.json","markdown":"https://secwatch.observer/filing/0001829126-25-009754.md","text":"https://secwatch.observer/filing/0001829126-25-009754.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1979414/000182912625009754/0001829126-25-009754-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1979414/000182912625009754/neonctechnologies_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T14:21:18.789617+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"ff8afa683a9ea40d18ea0d84c6320c8c3b2f36aa","claim":"NEONC TECHNOLOGIES HOLDINGS, INC. issued 111,732 shares of common stock to Saad Naja for $8.95 per share.","evidence_excerpt":"issue and sell 111,732 shares (the “Shares”) of common stock, $0.0001 par value per share of the Company (the “Common Stock”). The per share purchase price of the Shares is $8.95, which represents the closing price of the Common Stock as reported on the Nasdaq Capital Market on November 28, 2025. The Shares were sold for approximately $1 million. The","evidence_source":"SEC 8-K Item 3.02/3.03","evidence_url":"https://www.sec.gov/Archives/edgar/data/1979414/000182912625009754/0001829126-25-009754-index.htm","confidence":0.9,"family_label":"Equity Issuances","details":[{"label":"Security","value":"common stock"},{"label":"Shares","value":"111,732 shares"},{"label":"Purchaser","value":"Saad Naja"},{"label":"Consideration","value":"$8.95 per share"}],"fact_type":"equity_issuance"},{"claim_id":"1c9350052d5b6bfb83f1c1da8e5a9c908779bd58","claim":"NEONC TECHNOLOGIES HOLDINGS, INC. entered into Securities Purchase Agreement with Saad Naja valued at approximately $1 million (effective 2025-12-01).","evidence_excerpt":"On December 1, 2025, NeOnc Technologies Holdings, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Agreement”) with Saad Naja (the “Investor”) to issue and sell 111,732 shares (the “Shares”) of common stock, $0.0001 par value per share of the Company (the “Common Stock”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1979414/000182912625009754/0001829126-25-009754-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"Saad Naja"},{"label":"Value","value":"approximately $1 million"},{"label":"Effective","value":"2025-12-01"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}